Garenoxacin
≥98%
- Product Code: 190311
CAS:
194804-75-6
| Molecular Weight: | 230.27 g./mol | Molecular Formula: | C₂₃H₂₀F₂N₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08704542 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, Inert Gas |
Product Description:
Garenoxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class, primarily used in the treatment of bacterial infections. It demonstrates strong activity against both Gram-positive and Gram-negative bacteria, including strains resistant to other antibiotics. It is particularly effective in treating respiratory tract infections such as pneumonia and bronchitis due to its ability to penetrate lung tissue efficiently. Garenoxacin also shows utility in treating urinary tract infections and certain sexually transmitted diseases. Its mechanism involves inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and transcription, leading to bacterial cell death. Due to its pharmacokinetic profile, it allows for once-daily dosing, improving patient compliance. However, its use has been limited in some regions due to safety concerns associated with other fluoroquinolones, such as tendonitis and CNS effects.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 G | 10-20 days | ฿5,970.00 |
+
-
|
| 0.025 G | 10-20 days | ฿16,470.00 |
+
-
|
Garenoxacin
Garenoxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class, primarily used in the treatment of bacterial infections. It demonstrates strong activity against both Gram-positive and Gram-negative bacteria, including strains resistant to other antibiotics. It is particularly effective in treating respiratory tract infections such as pneumonia and bronchitis due to its ability to penetrate lung tissue efficiently. Garenoxacin also shows utility in treating urinary tract infections and certain sexually transmitted diseases. Its mechanism involves inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and transcription, leading to bacterial cell death. Due to its pharmacokinetic profile, it allows for once-daily dosing, improving patient compliance. However, its use has been limited in some regions due to safety concerns associated with other fluoroquinolones, such as tendonitis and CNS effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :